Retinal pigment epithelium rip with posterior uveitis after intravitreal brolucizumab in neovascular age-related macular degeneration

MeSH terms

• Angiogenesis Inhibitors / therapeutic use
• Antibodies, Monoclonal, Humanized / adverse effects
• Humans
• Intravitreal Injections
• Macular Degeneration*
• Retinal Pigment Epithelium
• Uveitis, Posterior* / diagnosis
• Uveitis, Posterior* / drug therapy
• Wet Macular Degeneration* / diagnosis
• Wet Macular Degeneration* / drug therapy